Skip to main content
. Author manuscript; available in PMC: 2015 Apr 21.
Published in final edited form as: JAMA. 2012 Aug 15;308(7):700–709. doi: 10.1001/jama.2012.9307

Table 1.

Baseline Characteristics by Condition and Partner Status

Characteristics PTSD-Identified Patients
Partners
CBCT (n = 20)a Wait List (n = 20)a Difference (95% CI)b CBCT (n = 20)a Wait List (n = 20)a Difference (95% CI)b
Age, mean (SD), y 40.4 (11.3) 33.8 (10.5) 6.6 (−13.6 to 0.4) 40.7 (12.5) 34.9 (10.0) 5.9 (−13.1 to 1.4)

Male 7 (35.0) 3 (15.0) 20.0 10 (50.0) 17 (85.0) −35.0c

Nonwhite 5 (25.0) 6 (30.0) −5.0 4 (20.0) 4 (20.0) 0

Relationship
 Married 8 (40.0) 5 (25.0) 15.0 8 (40.0) 5 (25.0) 15.0

  Length, mean (SD), y 8.1 (8.7) 5.4 (5.8) 2.7 (−7.6 to 2.2) 8.2 (9.0) 5.4 (5.8) −2.8 (−7.7 to 2.0)

 Previously divorced 5 (25.0) 5 (25.0) 0 4 (20.0) 1 (5.0) 15.0

Military veteran 6 (30.0) 3 (7.5) 22.5 1 (5.0) 0 5.0

Employment (at least part time) 12 (60.0) 12 (60.0) 0 13 (65.0) 13 (65.0) 0

Index trauma
 Adult sexual trauma 4 (20.0) 4 (20.0) 0

 Child sexual trauma 3 (15.0) 8 (40.0) −25.0

 Noncombat physical assault 4 (20.0) 2 (10.0) 10.0

 Motor vehicle collision 1 (5.0) 2 (10.0) −5.0

 Witnessing/learning about death/illness 2 (10.0) 3 (15.0) −5.0

 Combat 2 (10.0) 0 10.0

 Other 4 (20.0) 1 (5.0) 15.0

Years since trauma, median (range) 13.0 (1.0–44.0) 6.5 (0.5–42.0) 6.5

Any current comorbid diagnosesd 11 (55.0) 14 (70.0) −15.0 3 (15.0) 7 (35.0) −20.0

 Mood disorder 7 (35.0) 9 (45.0) −10.0 1 (5.0) 2 (10.0) −5.0

 Other anxiety disorder 5 (25.0) 7 (35.0) −10.0 2 (10.0) 3 (15.0) −5.0

 Substance abuse 0 0 0 0 1 (5.0) −5.0

 Other 2 (10.0) 2 (10.0) 0 0 2 (10.0) −10.0

Lifetime comorbid diagnosesd 19 (95.0) 20 (100.0) −5.0 15 (75.0) 13 (65.0) 10.0

 Mood disorder 18 (90.0) 17 (85.0) 5.0 12 (60.0) 9 (45.0) 15.0

 Other anxiety disordere 9 (45.0) 10 (50.0) −5.0 6 (30.0) 5 (25.0) 5.0

 Substance abuse or dependence 9 (45.0) 8 (40.0) 5.0 10 (50.0) 7 (35.0) 15.0

 Other 5 (25.0) 4 (20.0) 5.0 1 (5.0) 2 (10.0) −5.0

Stable psychotropic medications 7 (35.0) 11 (55.0) −20.0 7 (35.0) 2 (10.0) 25.0

Concurrent psychotherapy 8 (40.0) 7 (35.0) 5.0 7 (35.0) 5 (25.0) 10.0

Outcome measures, mean (SD)
 Clinician-Administered PTSD Scale (total) 69.5 (12.7) 74.8 (15.0) −5.3 (−3.5 to 14.2)

 PTSD Checklist (total self- and partner report) 50.3 (11.0) 58.5 (11.6) −8.2 (1.0 to 15.5)c 44.5 (11.8) 43.7 (16.0) 0.7 (−9.8 to 8.3)

 Dyadic Adjustment Scale (total) 101.3 (22.2) 98.1 (20.8) 3.2 (−16.9 to 10.6) 104.0 (21.0) 99.5 (19.9) 4.5 (−17.6 to 8.6)

 Beck Depression Inventory II (total) 23.0 (11.9) 22.9 (10.5) 0.1 (−7.4 to 7.1)

 State-Trait Anxiety Inventory state subscale 48.8 (12.6) 51.2 (12.0) −2.4 (−5.6 to 10.3)

State-Trait Anger Expression Inventory
  Trait subscale 23.7 (8.5) 22.7 (5.7) 1.0 (−5.6 to .3.7)

  Anger expression subscale 35.2 (13.0) 37.1 (7.9) −1.9 (−5.0 to 8.8)

Abbreviations: CBCT, cognitive-behavioral conjoint therapy; PTSD, posttraumatic stress disorder.

a

Data are expressed as No. (%) unless otherwise indicated.

b

Percentage difference between CBCT and wait list reported for categorical variables; mean difference and 95% CI reported for continuous variables. Negative values indicate smaller means or percentages in the CBCT condition.

c

Significantly different at P < .05.

d

All comorbid diagnoses were determined by the Structured Clinical Interview for DSM-IV–Patient Version.

e

Includes lifetime PTSD diagnosis in other anxiety disorder diagnosis category for partners.